Life isn't easy for people living with cancer and especially for young patients like filmmaker Jessica Wing whose illness and complications had restricted not only her movements, but also her life. After radiation and surgery, Jessica was thankful when her doctor suggested a medical treatment that has helped Jessica resume her routine.
Keywords: Bisphosphonates, metastases, metastasis, bone complications, multiple myeloma, leukemia, prostate cancer, lung cancer, Colon cancer, colorectal cancer, chemotherapy, osteoblast, osteoclast, radiation therapy, Zometa, Aredia
If one promising drug fails to help against chronic myeloid leukemia, what can be done? Listen to experts explain your options for hard to treat cancers.
Keywords: chronic myeloid leukemia, chronic myelogenous leukemia, CML, imatinib, Gleevec, side effects, intolerance, resistance, stem cell transplant, bone marrow transplant, dose escalation, drug holiday, clinical trials, BMS 354825, desatinib, AMN 107.
Tracking faulty chromosomes is routine for people with chronic myeloid leukemia. Listen as experts explain why sophisticated laboratory tests that count chromosomes are important in determining how well a patient is responding to therapy.
Keywords: Gleevec, Glevec, Glevic, Glivec, imatinib, interferon, Philadelphia chromosome, BCR-Abl, cancer gene, CML, Chronic Myeloid Leukemia, cancer research, translocation, translocations, mutations, cytogenetic response, molecular response, PCR, polymerase chain reaction
Mounting evidence from clinical trials shows that patients with chronic myeloid leukemia (CML) may have long-term treatment success forgoing the only known cure for their disease. Watch and listen as CML experts explain how a promising drug now complicates the decision facing many patients-whether to seek a bone marrow transplant.
Keywords: Chronic Myeloid Leukemia, CML, chronic myelogenous leukemia, bone marrow transplant, bone transplant, Gleevec, imatinib, interferon, side-effects, surgery, blood cells, blood cancer, white blood cells, doctor/middle-aged or older patient
Some treatment options are not available for patients with chronic myeloid leukemia when they are over 65 years old. But most can still look forward to a range of effective medical therapies and a good quality of life. Listen to one man's success story.
Keywords: CML, chronic myeloid leukemia, Gleevec, imatinib, bone marrow transplant, interferon, stem cell transplant, hydroxyurea, cytogenic testing
Researchers say blood from newborns' umbilical cords may prove valuable for people requiring a bone marrow transplant after high-dose chemotherapy treatment.
Keywords: cord blood, umbilical cord blood, stem cell transplant, bone marrow transplant, peripheral blood stem cells, leukemia, lymphoma, hematopoietic stem cells, chemotherapy, radiation therapy, graft versus host disease, graft vs host disease, graft vs. host disease
A routine check-up may find that you have too many white blood cells, a sign of leukemia. What can be done? Learn about leukemia and how new treatments are providing hope.
Keywords: Leukemia, blood cancers, cancers of the blood, lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, acute lymphocytic leukemia, chronic lymphocytic leukemia, bone marrow transplant, watchful waiting, targeted therapies, Rituxan, Gleevec, acute leukemia, chronic leukemia;
As with any disease, the accurate diagnosis of Lymphoma is crucial to providing the best, most effective treatment for each individual patient. So while new medications and treatment strategies get a lot of attention, advances in diagnostic technologies are also exciting and important. At the 42nd annual meeting of the American Society of Hematology in December, there was a lot of talk about something called a gene chip -- or DNA microarray analysis -- which has recently been used to diagnose Diffuse Large B-Cell Lymphoma. What is a gene chip and how does it work? How will it lead to more effective treatments? Our panel of experts will include Margaret Shipp, MD, who presented on this topic at the conference.
Keywords: lymphoma, non hodgkins lymphoma, nonhodgkins lymphoma, burkitts lymphoma, lymphoma symptoms, hodgkinslymphoma, mantle cell lymphoma, burkitt's lymphoma, lymphoma cancer, lymphoma types, nonhodgkin's lymphoma, lymphoma treatment, large cell lymphoma, nonhodgkin's lymphoma treatment, b cell lymphoma, indolent lymphoma, cutaneous lymphoma, leukemia and lymphoma
Targeted therapies—treatments that zero in on cancerous cells—are among the current treatments for fighting cancer. One type of targeted therapy, monoclonal antibodies, has made great progress in recent years. Find out how scientists developed these treatments and how they can offer new hope to people with cancer.
Keywords: Non Hodgkin's Lymphoma, Lymphoma, gilda's club, Zevalin, monoclonal antibodies, immune system, HAMA, chemotherapy, Rituxan, CHOP, radioimmunotherapy, CD20 antigen, targeted therapies, NHL, mouse antibodies, malignant cells, targeted therapy, rituximab, Herceptin, CamPath, chronic lymphocytic leukemia, human anti-mouse antibodies, Mab
Initially approved for specific types of non-Hodgkin's lymphoma, the monoclonal antibody Rituxan is now being used by to treat Chronic Lymphocytic Leukemia or CLL. At a recent medical conference, experts discussed the success of this stategy, as well as the use of other targeted therapies for CLL. Join Dr. Kanti Rai and Dr. Joseph Connors as they discuss the latest findings.
Keywords: rituxan, rituximab, targeted therapy, cll, leukemia, chronic lymphocytic leukemia, treatment, therapy, new data, research, ash, american society of hematology meeting, monoclonal antibody, antibody therapy, immunotherapy
Standard treatment for chronic myeloid leukemia can occasionally fail. New studies show an increasing number of alternative treatments may be available.
Keywords: chronic myeloid leukemia, chronic myelogenous leukemia, CML, imatinib, Gleevec, side effects, intolerance, resistance, stem cell transplant, bone marrow transplant, dose escalation, drug holiday, clinical trials, BMS 354825, BMS354825. dasatinib, desatinib, AMN 107, AMN107, interferon, IRIS trial, residual disease
A majority of people with CML do well with treatments. But a few will develop serious side effects or develop drug resistance. Listen to experts describe what can be done.
Keywords: Chronic Myeloid Leukemia, CML, chronic myelogenous leukemia, blood cancer, Gleevec, imatinib, resistance, relapse, bone marrow, stem cell, transplants, allogeneic transplants, BMS 354825, AMN 107. Combination therapy. Interferon, Ara-C, drug holidays, combination therapy
One of the greatest success stories in cancer treatment occurs in people with chronic myeloid leukemia. But treatments don't always work well in everyone. Learn what can happen.
Keywords: Chronic myeloid leukemia, CML, chronic myelogenous leukemia, blood cancer, Gleevec, imatinib, resistance, relapse, bone marrow, stem cell, transplants, stem cell transplantation, allogenetic transplants, BMS 354825, AMN 107
Chronic lymphocytic leukemia or CLL accounts for 25% of all leukemias in the U.S., most common in adults over 50. It affects certain white blood cells called lymphocytes with serious consequences for the body's immune system.
Keywords: Chronic lymphocytic leukemia, CLL, lymphocytes, white blood cells
The approval of Gleevec (imatinib) in 2001 changed the future for patients with chronic myeloid leukemia (CML). CML is now one of the most treatable forms of cancer. In some patients, however, their disease becomes resistant to the treatment. Listen to the story of how one patient, along with her oncologist, Dr. Hagop Kantarjian of the M.D. Anderson Cancer Center, managed her CML.
Keywords: cancer, leukemia, gleevec, bone cancer, amino acids, Philadelphia Chromosome, cancer research, bone marrow transplant, leukemia symptoms, acute leukemia, leukaemia, alternative cancer treatment, cml, chronic lymphocytic leukemia, cancer statistics, signal transduction, leukemia society, cancer cells, cancer research journal, cancer stages, liver cancer symptoms, cancer drugs, bone marrow transplants, acute lymphocytic leukemia, sti 571, childhood leukemia, bone marrow cancer, cancer photos, symptoms bone cancer, cancer vaccine, cancer cures, chronic myelogenous leukemia, chronic myeloid leukemia, acute myeloid leukemia, acute myelogenous leukemia, chronic leukemia, molecular response, cytogenetic response, hematologic, hematologic response, hematology
Hear one woman's story as she participates in a clinical trial to help fight CML.
Keywords: chronic myeloid leukemia, chronic myelogenous leukemia, CML, imatinib, Gleevec, drug holiday, BMS 354825, BMS354825, dasatinib, desatinib, AMN 107, AMN107, interferon
For patients with chronic myeloid leukemia, establishing a close relationship with their doctor is very important. With new treatment options available patients and doctors need to be able to communicate freely and be aware of the latest research developments. Find out how CML patients and the doctors who treat them, can work together to treat this disease.
Keywords: Chronic Myeloid Leukemia, CML, leukemia, Philadelphia chromosome, cancer, blood test, chromosome analysis, bone marrow, radiation, bone marrow transplant, stem cell transplant, treatment decisions, chronic phase, accelerated phase, blast phase, side effects, hematologic response, cytogenetic response, molecular response, STI-571, Gleevec, imatinib, chemotherapy, interferon, CML symptoms, flu-like symptoms, patient experiences, blood counts
In treating Chronic Myeloid Leukemia (CML), doctors admit: they don't have all the answers. So patients must learn enough about CML to help make good treatment decisions. That means understanding the natural course of the disease and how his or her own body responds to therapy. Tune in as doctors describe what CML patients need to know.
Keywords: Chronic Myeloid Leukemia, CML, leukemia, Philadelphia chromosome, BCR- able, treatment decisions, chromosome analysis, chronic phase, accelerated phase, blast phase, disease progression, STI-571, Gleevec, imatinib, cancer, side effects, bone marrow transplant, stem cell transplant, donor, CML therapy, CML treatment, chemotherapy, hematologic response, cytogenetic response, molecular response, interferon, CML symptoms, flu-like symptoms, patient experiences, blood test, blood counts, bone marrow,
The genetics of chronic myeloid leukemia are now well understood. Listen to researchers as they explain the path they took to their remarkable discoveries beginning over 40 years ago, in a research lab in Philadelphia.
Keywords: Gleevec, Glevec, Glevic, Glivec, imatinib, interferon, Philadelphia chromosome, BCR-Abl, cancer gene, CML, Chronic Myeloid Leukemia, cancer research, Peter Nowell, Janet Rowley, translocation, translocations, mutations, Hungerford
Even "targeted" therapy for chronic myeloid leukemia is not without side effects. Some, like low blood counts, are serious. Hear how one patient, along with her oncologist, Dr. Neil Shah of UCLA, managed the side effects of her CML treatment.
Keywords: cancer, leukemia, gleevec, bone cancer, amino acids, Philadelphia Chromosome, cancer research, bone marrow transplant, leukemia symptoms, acute leukemia, leukaemia, alternative cancer treatment, cml, chronic lymphocytic leukemia, cancer statistics, signal transduction, leukemia society, cancer cells, cancer research journal, cancer stages, liver cancer symptoms, cancer drugs, bone marrow transplants, acute lymphocytic leukemia, sti 571, childhood leukemia, bone marrow cancer, cancer photos, symptoms bone cancer, cancer vaccine, cancer cures, chronic myelogenous leukemia, chronic myeloid leukemia, acute myeloid leukemia, acute myelogenous leukemia, chronic leukemia, molecular response, cytogenetic response, hematologic, hematologic response, hematology
Blood tests are routine in the treatment of chronic myeloid leukemia. Hear how one patient learned how to follow her treatment progress by studying her complicated lab tests.
Keywords: CML, chronic myeloid leukemia, chronic myelogenous leukemia, Gleevec, STI 571, interferon, ARA C, leukemia, blood cancer, cytogenetic, cytogenetic testing, bone marrow, fluorescence In situ hybridization, FISH, polymerase chain reaction, PCR
A wide range of laboratory tests is used to monitor a patient's response to therapy for chronic myeloid leukemia. Listen to experts explain the tests and their range of sensitivity.
Keywords: Chronic myeloid leukemia, CML, chronic myelogenous leukemia, blood cancer, Gleevec, imatinib, resistance, relapse, bone marrow, stem cell, transplants, allogeneic transplants, allogenic transplants, BMS 354825, AMN 107, blood tests, bone marrow tests, cytogenetic testing, FISH, fluorescence in situ hybridization, PCR, polymerase chain reaction.
Rituxan is a monoclonal antibody therapy that was approved several years ago for specific types of non-Hodgkin's lymphoma . At the 2001 American Society for Hematology meeting in Orlando, researchers showed how Rituxan can be used to treat blood disorders other than cancer. Join Dr. Craig Kessler as he discusses the latest developments.
Keywords: rituxan, rituximab, targeted therapy, cll, leukemia, chronic lymphocytic leukemia, treatment, therapy, new data, research, ash, american society of hematology meeting, monoclonal antibody, antibody therapy, immunotherapy
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
